Atlas Trials

Effect of LIXIsenatide on the Renal System

Clinical trial NCT02276196 · COMPLETED

Trial details

NCT number
NCT02276196
Sponsor
Amsterdam UMC, location VUmc
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetic Kidney DiseaseDiabetic NephropathyDiabetes MellitusGlucagon-Like Peptide 1
Start date
2014-09-01
Primary completion
2016-04-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.